Navigation Links
Kosan's Lead Hsp90 Inhibitor, Tanespimycin, Shows High Level of Activity in Trastuzumab Resistant/Refractory HER2-Positive Breast Cancer in a Phase 2 Trial
Date:6/3/2008

Data Presented at ASCO Show 26% Partial Response, 63% Clinical Benefit

Incidence

HAYWARD, Calif., June 3 /PRNewswire-FirstCall/ -- Kosan Biosciences Incorporated (Nasdaq: KOSN) today announced that its lead Hsp90 inhibitor, tanespimycin, demonstrated a high level of antitumor activity in a Phase 2 trial when administered in combination with trastuzumab (Herceptin(R)) to patients with HER2-positive metastatic breast cancer whose disease had either progressed after, or did not respond to, treatment with trastuzumab immediately prior to entering the trial. Of 27 evaluable patients, 17 patients showed clinical benefit including 7 patients with partial response (PR), 5 patients with tumor regression (minor response or MR) and 5 patients with extended stable disease (SD, greater than 4 cycles), yielding an overall clinical benefit incidence of 63%. Common toxicities were mainly mild to moderate and included fatigue and gastrointestinal symptoms.

Updated data from the Phase 2 trial were presented in a poster titled, "Phase 2 trial of the Hsp90 inhibitor tanespimycin (Tan) + trastuzumab (T) in patients (pts) with HER2-positive metastatic breast cancer (MBC)," by Shanu Modi, M.D., of Memorial Sloan-Kettering Cancer Center, at the 44th American Society of Clinical Oncology (ASCO) Annual Meeting being held in Chicago, IL.

"The response data from this Phase 2 trial of tanespimycin plus trastuzumab have grown stronger as more patients have been treated, underscoring our observation that tanespimycin is a highly active and tolerable agent in patients whose disease is refractory to trastuzumab," said Clifford A. Hudis, M.D., Chief, Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Cent
'/>"/>

SOURCE Kosan Biosciences Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the GTCbio Cancer Drugs Research & Development Conference
2. Kosan Initiates Phase 2 Trial of Alvespimycin, Second-Generation Hsp90 Inhibitor, in HER2-Positive Metastatic Breast Cancer
3. Kosan Presents Updated Data on Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma at Ash
4. First High-Res 3-D Structures of Mammalian HSP90 Protein Solved, Key to Better Targets for AIDS, Sepsis, Cancer Drugs
5. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
6. Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
7. BiPar Sciences Expands Clinical Development of BSI-201, A Novel PARP Inhibitor, With Phase 2 Trial in Uterine Cancer
8. BiPar Sciences Announces Clinical Data Presentations on Lead PARP Inhibitor, BSI-201, at 40th American Society of Clinical Oncology Annual Meeting
9. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
10. SuperGen Identifies Lead PIM Kinase Inhibitor, SGI-1776, That Causes Tumor Regression in AML Xenograft Models
11. SuperGens DNA Methyltransferase Inhibitor, S-110, Improves In Vivo Efficacy Profile of Decitabine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... BOHEMIA, N.Y. , July 25, 2014 /PRNewswire-iReach/ -- Dr. ... Pediatrics clinic, GPM Pediatrics, reacts to a recent study, ... adulthood. Photo - http://photos.prnewswire.com/prnh/20140723/129709 ... mothers exposed to severe stress are more likely than others ... occurred months before pregnancy." There were two specific ...
(Date:7/24/2014)... und MARSEILLE , Frankreich, ... , Weltweite Exklusivlizenz der Universität ... die Entwicklung von Tests auf SF3B1-Mutationen, einschließlich ... Neuer Test weist Mutationen des SF3B1-Gens ... Syndromen) einen günstigen Krankheitsverlauf vermuten lassen  ...
(Date:7/24/2014)... 2014  IRIDEX Corporation (NASDAQ: IRIX ) ... 2014 financial results after the market closes on ... release, the Company will host a conference call with ... on Thursday, July 31, 2014 to ... developments. Interested parties may access the live ...
Breaking Medicine Technology:Dr. Michael Gabriel of GPM Pediatrics, a Noted Staten Island Pediatrics Clinic, Comments on Study, Which Names Grief as a Cause of Obesity in Children 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 3QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 5
... Spirus Medical announced today that it has obtained ... and Welfare for the company,s proprietary ENDO-EASE line of ... "over-tubes" that use a spiral design utilizing simple rotation ... According to Spirus Medical, the Endo-Ease line is well ...
... Companies to Lead Public and Investor Relations Efforts -- BEIJING, Sept. 8 /PRNewswire-Asia-FirstCall/ -- ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by ...
Cached Medicine Technology:Spirus Medical Announces Japanese Regulatory Approval to Market ENDO-EASE® Product Line 2Lotus Pharmaceuticals Announces Engagement of RedChip Companies to Lead Public and Investor Relations Efforts 2Lotus Pharmaceuticals Announces Engagement of RedChip Companies to Lead Public and Investor Relations Efforts 3Lotus Pharmaceuticals Announces Engagement of RedChip Companies to Lead Public and Investor Relations Efforts 4Lotus Pharmaceuticals Announces Engagement of RedChip Companies to Lead Public and Investor Relations Efforts 5Lotus Pharmaceuticals Announces Engagement of RedChip Companies to Lead Public and Investor Relations Efforts 6Lotus Pharmaceuticals Announces Engagement of RedChip Companies to Lead Public and Investor Relations Efforts 7Lotus Pharmaceuticals Announces Engagement of RedChip Companies to Lead Public and Investor Relations Efforts 8
(Date:7/25/2014)... (PRWEB) July 25, 2014 Health Advocate™, ... and a subsidiary of West Corporation, is introducing its ... Analytics: Reduce Costs and Enhance Quality. , The webinar ... 11 AM ET and again at 2 PM ET. ... please visit http://www.HealthAdvocate.com/Analytics or call 866.799.2655. , ...
(Date:7/25/2014)... Washington, D.C.-- July 25, 2014 -- The Elizabeth ... licensing agreement between the Medicines Patent Pool (MPP) ... tenofovir alafenamide fumarate (TAF), a promising new HIV ... International AIDS Conference (AIDS 2014) in Melbourne, Australia. ... III clinical trials, early data suggests it could ...
(Date:7/25/2014)... 2014 DON’T PAUSE is a popular natural ... hot flashes, mood swings, burning tongue menopause and ... Ershadi. The AntiAging Institute of California is now offering a ... to try this revolutionary product. For a limited time, women ... third bottle at no charge. , Water retention ...
(Date:7/25/2014)... 25, 2014 (HealthDay News) -- Dietary changes can dramatically ... a daily basis, according to a new study. ... might help detect and ease flare-ups for people with ... colitis and Crohn,s disease), the researchers said. Trillions ... effect on human health isn,t well understood, the Massachusetts ...
(Date:7/25/2014)... 2014 The Futon Shop celebrates ... Sale. The Futon Shop has been around since 1976 as ... grown from a few handmade futon mattresses a month, to ... futon mattresses. , The Futon Shop futon mattresses were ... desire to sleep on natural fibers was a growing movement. ...
Breaking Medicine News(10 mins):Health News:Health Advocate™, Inc., Holds Webinar to Introduce Provider-Centered Analytics 2Health News:Health Advocate™, Inc., Holds Webinar to Introduce Provider-Centered Analytics 3Health News:AntiAging Institute of California Now Offers DON'T PAUSE for Menopause with a Special Promotion 2Health News:Diet Changes Can Alter Gut Bacteria, Study Says 2Health News:Organic Mattress Manufacturer Celebrates 38 Years Of Being In Business 2Health News:Organic Mattress Manufacturer Celebrates 38 Years Of Being In Business 3
... Vice President of India wants the Government and ... of blood and organ donation. In India., ,Inaugurating ... here, the Vice President asked the government and people to ... donors of blood and organs must be encouraged to save ...
... Researchers have found that physical inactivity due to lack ... surrounding area make rural people obese.// ,The study ... link between obesity and the environmental factors within rural ... of Public Health research that examines the environmental features ...
... dangerous proportions, and now a pill that claims to ... be just what the doctor// ordered. ,This is ... circles. Accomplia, as the pill is called, renders the ... the cravings in their tracks. ,Alarmingly, 23%of ...
... improve the oral health of children and adolescents but ... in an international session of Dental Health. ... Japan, Kuwait, Scotland, Thailand reported in the 84th General ... more work were needed to be done in improving ...
... of Archives of Internal Medicine, which is one of the ... may have more chronic sleep problems than women who do ... women in menopause experience hot flashes, heightened sensations to heat ... hot flashes often occur during the night and have been ...
... they may gain about 20 pounds, according to a new ... 5 pounds// to 15 pounds. ,The findings highlight ... along with smoking cessation programs, say study authors Daniel Eisenberg ... University of California, Berkeley. ,The authors are quick ...
Cached Medicine News:Health News:Environmental Factors Leads to Obesity in Rural Communities 2Health News:Unhealthy Oral Habits among Teenagers – Reported Dental Health Authoritie 2Health News:Women With Severe Hot Flashes May Have Increased Chronic Sleep Problem 2Health News:Smokers are Prone to Weight Gain After Quitting 2
iSleep 20i is an advanced high performance CPAP with outstanding self-adjusting i‑technology....
Spectrum Dynamics empowers Nuclear Imaging with the SmartR Technology,of the D-SPECT Cardiac Imaging System. The D-SPECT is powered by BroadView Technology to provide unprecedented throughput, whil...
Diagnosoft HARP is designed for rapid analysis of tagged cardiac MR images using the HARP technology, which is packaged into an intuitive, easy-to-use graphic user interface....
... accurately differentiates clinically significant progression of ... providing an advanced, proven method to ... patients. , ,The software applies knowledge ... in which the actual test/retest variability ...
Medicine Products: